Results 21 to 30 of about 1,117 (238)
The data contain the land developability index at the county level in the ...
Chi, Guangqing, Hung Chak Ho
core +3 more sources
In silico prediction of post-translational modifications in therapeutic antibodies
Monoclonal antibodies are susceptible to chemical and enzymatic modifications during manufacturing, storage, and shipping. Deamidation, isomerization, and oxidation can compromise the potency, efficacy, and safety of therapeutic antibodies.
Shabdita Vatsa
doaj +1 more source
Reversible antibody self-association, while having major developability and therapeutic implications, is not fully understood or readily predictable and correctable.
Carl Mieczkowski +8 more
doaj +1 more source
Machine learning has been recently used to predict therapeutic antibody aggregation rates and viscosity at high concentrations (150 mg/ml). These works focused on commercially available antibodies, which may have been optimized for stability.
Pin-Kuang Lai +4 more
doaj +1 more source
Antibody drugs should exhibit not only high-binding affinity for their target antigens but also favorable physicochemical drug-like properties. Such drug-like biophysical properties are essential for the successful development of antibody drug products ...
Hristo L. Svilenov +4 more
doaj +1 more source
High concentration formulation developability approaches and considerations
The growing need for biologics to be administered subcutaneously and ocularly, coupled with certain indications requiring high doses, has resulted in an increase in drug substance (DS) and drug product (DP) protein concentrations.
Jonathan Zarzar +5 more
doaj +1 more source
Application of a Refined Developability Classification System
S.1090-1100In 2010, the Developability Classification System was proposed as an extension of the Biopharmaceutics Classification System to align the classification system with the need for early evaluation of drug candidates according to their ...
Butler, J. +3 more
core +1 more source
Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies
To combat the COVID-19 pandemic, potential therapies have been developed and moved into clinical trials at an unprecedented pace. Some of the most promising therapies are neutralizing antibodies against SARS-CoV-2.
Andrew Dippel +31 more
doaj +1 more source
Antibodies must bind their targets with high affinity and specificity to achieve useful therapeutic activity. They must also possess suitable developability properties (e.g.
Ammar Arsiwala +27 more
doaj +1 more source
zbMATH Open Web Interface contents unavailable due to conflicting licenses.
openaire +2 more sources

